↓ Skip to main content

Cochrane Database of Systematic Reviews

Haloperidol dose for the acute phase of schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter
6 X users
f1000
1 research highlight platform

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
206 Mendeley
Title
Haloperidol dose for the acute phase of schizophrenia
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd001951.pub2
Pubmed ID
Authors

Lorna Donnelly, John Rathbone, Clive E Adams

Abstract

Haloperidol is a benchmark, accessible antipsychotic drug against which the effects of newer treatments are gauged.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 206 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 16%
Researcher 28 14%
Student > Bachelor 22 11%
Student > Ph. D. Student 20 10%
Other 10 5%
Other 33 16%
Unknown 61 30%
Readers by discipline Count As %
Medicine and Dentistry 58 28%
Psychology 24 12%
Nursing and Health Professions 14 7%
Social Sciences 9 4%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Other 25 12%
Unknown 69 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2016.
All research outputs
#8,128,007
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#9,334
of 13,140 outputs
Outputs of similar age
#65,864
of 213,182 outputs
Outputs of similar age from Cochrane database of systematic reviews
#172
of 232 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,182 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 232 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.